Join The Conversation Card Front 01 Copy

The Medtechy Daily: October 30

Posted on October 30, 2018 by Medtech[y] Staff

The Medtechy Daily provides the latest news and insight for the medical technology industry, including medical device, biotech and digital health.

Tweet of the Day:


Many doctors writing clinical practice guidelines receive undisclosed industry payments, study finds. Last month, controversy stemming from undisclosed financial relationships with the drug industry led to the resignation of one the top breast cancer doctors in the country. But two new studies have found that the issue of financial conflicts of interest in medicine goes beyond just one doctor. (MedCityNews)

Boston Scientific Structural Heart Benefits from WATCHMAN Focus. Boston Scientific beat earnings estimates last week and their Structural Heart business unit received a boost due to the increased focus on their WATCHMAN device. The company also raised Structural Heart's revenue guidance from $450 million to $475 million to reflect continued WATCHMAN and ACURATE strength, plus the impact of the Claret acquisition. (Medtechy)

Lucrative Drug Trials Prompt Regional Hospitals to Join Forces. Regional hospitals across the U.S. are banding together to make it easier for pharmaceutical companies to use their facilities for clinical trials, a strategy that could boost revenue and give drugmakers increased access to patients. (Bloomberg)

Everything you need to know about CBD, the cannabis elixir that doesn’t get you high. Cannabidiol, a chemical component of cannabis known as CBD, has been popping up at an increasing number of bars and coffee shops in major cities in recent years. Without the psychoactive components in marijuana, the substance reportedly offers some of the anti-anxiety and anti-inflammatory benefits of the drug without getting a consumer high. (MarketWatch)

How One Hospital Improved Patient Safety in 10 Minutes a Day. Most modern health care improvements seem to involve expensive technology and an uncomfortable amount of change management. But clinical and nonclinical staff at the Rotterdam Eye Hospital have improved patient care and raised staff morale at a very modest cost: 10 minutes a day and a special deck of cards. (Harvard Business Review)

Eye scan may detect Alzheimer's disease in seconds. Two new studies now suggest that a noninvasive eye scan could soon be used to catch Alzheimer's disease early. (MedicalNewsToday)

Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows. The latest admonishment from the FDA's promo police is an unusual one. In it, the agency scolds an Eisai sales rep accused of misleading healthcare professionals during a presentation on antiseizure drug Fycompa. (FiercePharma)